Exelon (EXC) Stock Forecast & Price Target

$46.86 +0.86 (+1.87%)

As of 04:00 PM Eastern

Exelon - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 9 Analyst Ratings

Sell
0

Hold
4

Buy
5

Based on 9 Wall Street analysts who have issued ratings for Exelon in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 9 analysts, 4 have given a hold rating, and 5 have given a buy rating for EXC.

Consensus Price Target

$45.13
-3.70% Downside

According to the 9 analysts' twelve-month price targets for Exelon, the average price target is $45.13. The highest price target for EXC is $48.00, while the lowest price target for EXC is $42.00. The average price target represents a forecasted downside of -3.70% from the current price of $46.86.

Get the Latest News and Ratings for EXC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Exelon and its competitors.

EXC Analyst Ratings Over Time

Type	Current Forecast 4/14/24 to 4/14/25	1 Month Ago 3/15/24 to 3/15/25	3 Months Ago 1/15/24 to 1/14/25	1 Year Ago 4/15/23 to 4/14/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	5 Buy rating(s)	5 Buy rating(s)	3 Buy rating(s)	2 Buy rating(s)
Hold	4 Hold rating(s)	4 Hold rating(s)	5 Hold rating(s)	9 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$45.13	$44.13	$42.38	$39.09
Forecasted Upside	-3.70% Downside	-0.15% Downside	11.75% Upside	7.16% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Hold	Hold

Remove Ads

EXC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

EXC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Exelon Stock vs. The Competition

Type	Exelon	Utilities Companies	S&P 500
Consensus Rating Score	2.56	2.52	2.54
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	-3.70% Downside	21.89% Upside	25.85% Upside
News Sentiment Rating	Very Positive News See Recent EXC News	Positive News	Positive News

Remove Ads

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
3/21/2025	UBS Group 3 of 5 stars	Daniel Ford Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$45.00 ➝ $47.00	+6.52%
3/20/2025	Morgan Stanley 3 of 5 stars	David Arcaro Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Equal Weight ➝ Equal Weight	$46.00 ➝ $48.00	+8.17%
2/25/2025	Barclays 3 of 5 stars	Nicholas Campanella Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$42.00 ➝ $48.00	+10.73%
2/13/2025	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Weisel Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Sector Perform ➝ Sector Perform	$42.00 ➝ $44.00	+2.00%
2/4/2025	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform
1/23/2025	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Pourreza Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy
1/21/2025	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Durgesh Chopra Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	In-Line ➝ Outperform	$43.00 ➝ $44.00	+11.62%
9/19/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$46.00	+17.08%
8/2/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$40.00 ➝ $42.00	+9.12%
1/19/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$38.00 ➝ $36.00	+2.53%
Get the Latest News and Ratings for EXC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Exelon and its competitors with MarketBeat's FREE daily newsletter.
1/10/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$36.00 ➝ $39.00	+7.03%
1/8/2024	Seaport Res Ptn Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Storozynski Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral
12/19/2023	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Sector Perform ➝ Sector Perform	$45.00 ➝ $38.00	+9.16%
12/18/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Overweight ➝ Neutral	$41.00	+18.09%
6/7/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Sell	$39.00	-3.32%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 12:38 AM ET.

Should I Buy Exelon Stock? EXC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, April 8, 2025. Please send any questions or comments about these Exelon pros and cons to contact@marketbeat.com.

Exelon
Bull Case

Here are some ways that investors could benefit from investing in Exelon Co.:

Exelon Co. recently reported earnings per share (EPS) of $0.64, surpassing analysts' expectations of $0.59, indicating strong financial performance and effective management.
The company has increased its quarterly dividend to $0.40, up from $0.38, which translates to an annualized dividend of $1.60 and a yield of 3.53%. This increase reflects a commitment to returning value to shareholders.
Exelon Co. has a solid return on equity of 9.52%, suggesting that the company is efficient in generating profits from its equity investments, which is a positive indicator for potential investors.
Recent analyst upgrades, including a "buy" rating from Guggenheim and an "outperform" rating from Evercore ISI, suggest growing confidence in the company's future performance.
The current stock price is approximately $40.57, which may present a buying opportunity for investors looking to enter at a favorable valuation.

Exelon
Bear Case

Investors should be bearish about investing in Exelon Co. for these reasons:

Despite the recent earnings beat, the company's net margin of 10.68% may indicate limited profitability compared to competitors, which could be a concern for investors seeking higher returns.
The dividend payout ratio stands at 65.31%, which means a significant portion of earnings is being distributed as dividends. This could limit the company's ability to reinvest in growth opportunities.
Insider ownership is relatively low at 0.10%, which may raise concerns about alignment between management and shareholder interests, potentially affecting long-term performance.
While the stock has received several upgrades, four analysts still rate it as a hold, indicating some uncertainty about its future performance and potential for growth.
Recent insider selling, including a significant transaction by an executive vice president, may signal a lack of confidence in the stock's short-term prospects, which could deter potential investors.

EXC Forecast - Frequently Asked Questions

: According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for Exelon is $45.13, with a high forecast of $48.00 and a low forecast of $42.00.
: 9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Exelon in the last twelve months. There are currently 4 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" EXC shares.
: According to analysts, Exelon's stock has a predicted downside of -3.70% based on their 12-month stock forecasts.
: Over the previous 90 days, Exelon's stock had 2 upgrades by analysts.
: Exelon has been rated by research analysts at Barclays, BMO Capital Markets, Evercore ISI, Guggenheim, Morgan Stanley, Scotiabank, and UBS Group in the past 90 days.
: Analysts like Exelon more than other "utilities" companies. The consensus rating score for Exelon is 2.56 while the average consensus rating score for "utilities" companies is 2.52. Learn more on how EXC compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NASDAQ:EXC) was last updated on 4/14/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Exelon (EXC) Stock Forecast & Price Target